16 results on '"Zelniker, Thomas A."'
Search Results
2. Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.
3. Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.
4. Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes: JACC State-of-the-Art Review.
5. First real-world experience with CardioSecur® in the preclinical setting – When time does matter
6. INFLAMMATORY AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH RENAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: INSIGHTS FROM SAVOR-TIMI 53.
7. PROGNOSTIC VALUE OF BIOMARKER OF COLLAGEN TURNOVER (C-TERMINAL TELOPEPTIDE) IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES: INSIGHTS FROM MERLIN-TIMI 36.
8. Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies.
9. Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial.
10. ELEVATED TUMOR MARKERS IN PATIENTS RECOVERED FROM SARS-COV-2 INFECTION WITH LONG-TERM CARDIOVASCULAR SYMPTOMS.
11. EFFECT OF DOACS VERSUS WARFARIN BY ASCVD STATUS IN 58,634 PATIENTS WITH ATRIAL FIBRILLATION: A POOLED ANALYSIS OF 4 RANDOMIZED TRIALS.
12. Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization.
13. Right ventricular long axis strain-validation of a novel parameter in non-ischemic dilated cardiomyopathy using standard cardiac magnetic resonance imaging.
14. BIOMARKER PREDICTION OF MAJOR CORONARY EVENTS AND COMPLEX REVASCULARIZATION PROCEDURES IN PATIENTS WITH STABLE ATHEROSCLEROSIS.
15. TICAGRELOR AND MAJOR ADVERSE LIMB EVENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
16. DAPAGLIFLOZIN AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND PRIOR MYOCARDIAL INFARCTION: A SUB-ANALYSIS FROM DECLARE TIMI-58 TRIAL.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.